BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 2823962)

  • 1. The brain response to the bee venom peptide MCD. Activation and desensitization of a hippocampal target.
    Bidard JN; Gandolfo G; Mourre C; Gottesmann C; Lazdunski M
    Brain Res; 1987 Aug; 418(2):235-44. PubMed ID: 2823962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analogies and differences in the mode of action and properties of binding sites (localization and mutual interactions) of two K+ channel toxins, MCD peptide and dendrotoxin I.
    Bidard JN; Mourre C; Gandolfo G; Schweitz H; Widmann C; Gottesmann C; Lazdunski M
    Brain Res; 1989 Aug; 495(1):45-57. PubMed ID: 2550111
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term potentiation of synaptic transmission in the hippocampus induced by a bee venom peptide.
    Cherubini E; Ben Ari Y; Gho M; Bidard JN; Lazdunski M
    Nature; 1987 Jul 2-8; 328(6125):70-3. PubMed ID: 2885754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Behaviors and neurodegeneration induced by two blockers of K+ channels, the mast cell degranulating peptide and Dendrotoxin I.
    Mourre C; Lazdunski M; Jarrard LE
    Brain Res; 1997 Jul; 762(1-2):223-7. PubMed ID: 9262178
    [TBL] [Abstract][Full Text] [Related]  

  • 5. K+ channel involvement in induction of synaptic enhancement by mast cell degranulating (MCD) peptide.
    Kondo T; Ikenaka K; Fujimoto I; Aimoto S; Kato H; Ito K; Taguchi T; Morita T; Kasai M; Mikoshiba K
    Neurosci Res; 1992 Apr; 13(3):207-16. PubMed ID: 1376885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The receptor site for the bee venom mast cell degranulating peptide. Affinity labeling and evidence for a common molecular target for mast cell degranulating peptide and dendrotoxin I, a snake toxin active on K+ channels.
    Rehm H; Bidard JN; Schweitz H; Lazdunski M
    Biochemistry; 1988 Mar; 27(6):1827-32. PubMed ID: 2454131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Two potent central convulsant peptides, a bee venom toxin, the MCD peptide, and a snake venom toxin, dendrotoxin I, known to block K+ channels, have interacting receptor sites.
    Bidard JN; Mourre C; Lazdunski M
    Biochem Biophys Res Commun; 1987 Feb; 143(1):383-9. PubMed ID: 2435287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High affinity receptors for the bee venom MCD peptide. Quantitative autoradiographic localization at different stages of brain development and relationship with MCD neurotoxicity.
    Mourre C; Bidard JN; Lazdunski M
    Brain Res; 1988 Apr; 446(1):106-12. PubMed ID: 3370474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The characterization of high-affinity binding sites in rat brain for the mast cell-degranulating peptide from bee venom using the purified monoiodinated peptide.
    Taylor JW; Bidard JN; Lazdunski M
    J Biol Chem; 1984 Nov; 259(22):13957-67. PubMed ID: 6501283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Basic peptides in bee venom, VI. Structure-activity studies on the anti-inflammatory effects of derivatives and fragments of the MCD-peptide (author's transl)].
    Martin W; Hartter P
    Hoppe Seylers Z Physiol Chem; 1980 Apr; 361(4):525-35. PubMed ID: 7380393
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects on behaviour and EEG of single chain phospholipases A2 from snake and bee venoms injected into rat brain: search for a functional antagonism.
    Gandolfo G; Lambeau G; Lazdunski M; Gottesmann C
    Pharmacol Toxicol; 1996 May; 78(5):341-7. PubMed ID: 8737971
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solid phase synthesis and biological activity of mast cell degranulating (MCD) peptide: a component of bee venom.
    Buku A; Blandina P; Birr C; Gazis D
    Int J Pept Protein Res; 1989 Feb; 33(2):86-93. PubMed ID: 2468626
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mast cell degranulating peptide induces the expression of the c-fos proto-oncogene in hippocampus.
    Séquier JM; Lazdunski M
    Eur J Pharmacol; 1990 May; 180(1):179-81. PubMed ID: 2365001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Riluzole prevents hyperexcitability produced by the mast cell degranulating peptide and dendrotoxin I in the rat.
    Stutzmann JM; Böhme GA; Gandolfo G; Gottesmann C; Lafforgue J; Blanchard JC; Laduron PM; Lazdunski M
    Eur J Pharmacol; 1991 Feb; 193(2):223-9. PubMed ID: 2050198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The bee venom active compound melittin protects against bicuculline-induced seizures and hippocampal astrocyte activation in rats.
    Soares-Silva B; Beserra-Filho JIA; Morera PMA; Custódio-Silva AC; Maria-Macêdo A; Silva-Martins S; Alexandre-Silva V; Silva SP; Silva RH; Ribeiro AM
    Neuropeptides; 2022 Feb; 91():102209. PubMed ID: 34808488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of beta-bungarotoxin binding to brain membranes by mast cell degranulating peptide, toxin I, and ethylene glycol bis (beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid.
    Schmidt RR; Betz H; Rehm H
    Biochemistry; 1988 Feb; 27(3):963-7. PubMed ID: 3130091
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MCD peptide and dendrotoxin I activate c-fos and c-jun expression by acting on two different types of K+ channels. A discrimination using the K+ channel opener lemakalim.
    Heurteaux C; Lazdunski M
    Brain Res; 1991 Jul; 554(1-2):22-9. PubMed ID: 1933303
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Release of endogenous excitatory amino acids and proteins by the mast cell degranulating peptide in the hippocampus.
    Aniksztejn L; Charriaut-Marlangue C; Roisin MP; Ben-Ari Y
    Pflugers Arch; 1989; 414 Suppl 1():S123-4. PubMed ID: 2571118
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurotoxicity of apamin and MCD peptide upon central application.
    Habermann E
    Naunyn Schmiedebergs Arch Pharmacol; 1977 Nov; 300(2):189-91. PubMed ID: 593441
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-inflammatory activity of bee venom peptide 401 (mast cell degranulating peptide) and compound 48/80 results from mast cell degranulation in vivo.
    Banks BE; Dempsey CE; Vernon CA; Warner JA; Yamey J
    Br J Pharmacol; 1990 Feb; 99(2):350-4. PubMed ID: 2328399
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.